Fund Evaluator:
iShares Health Innovation Active ETF (BMED)
Follow This Fund
Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.55% C
Expense Ratio
$13 Mil
Assets
Open
Status
na
12b-1 Fee
0.24%
TTM Yield
0.00%
Max Load
109%
Portfolio Turnover
Best Performing in Health Over the Last Year
| 67.1% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 66.9% | Fidelity Advisor Biotechnology I (FBTIX) |
| 58.0% | Fidelity Select Biotechnology (FBIOX) |
| 54.2% | Rydex Biotechnology Inv (RYOIX) |
| 49.7% | Eventide Healthcare & Life Sciences N (ETNHX) |
Data as of 8/31/2026
9.1% B
1-Mo Return
18.0% C
3-Mo Return
11.9% D
YTD Return
29.7% C
1-Yr Return
12.3% D
3-Yr Return
2.1% D
5-Yr Return
0.81 B
Category Risk Index
1.35
Total Risk Index
Fund Details
Fund Family
BlackRock
Inception Date
9/29/2020
Share Class Type
Equity Investment Style
Mid-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
MSCI ACWI NR USD: 100%
Additional Fund Details
iShares Health Innovation Active ETF Overview
BMED Trailing NAV Total Returns Data as of 8/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| BMED Return (NAV) | 9.1% | 18.0% | 29.7% | 12.3% | 2.1% | na |
| BMED Grade | B | C | C | D | D | na |
| +/- Category | 4.1% | 4.5% | -3.2% | -0.8% | -3.1% | na |
| Health Avg | 5.0% | 13.4% | 32.9% | 13.1% | 5.2% | 10.2% |
| BMED Tax Cost Ratio | na | na | 0.1% | 0.0% | 0.0% | na |
BMED Annual NAV Total ReturnsData as of 8/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| BMED Return (NAV) | 11.9% | 21.3% | 1.8% | 5.7% | -19.5% | -4.0% | na | na | na | na | na |
| BMED Grade | D | C | C | A | C | D | na | na | na | na | na |
| +/- Category | -0.6% | 0.7% | -0.7% | 0.1% | -10.1% | -12.7% | na | na | na | na | na |
| Health Avg | 12.5% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 16.5% |
| Total Risk Index: | 1.35 - Above Average |
| Category Risk Index: | 0.81 - Below Average |
| Category Risk Grade: | B (33% Rank) |
| Beta: | 0.77 |
| R-Squared: | 33% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Mid-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.2% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | |
| Total Assets: | $13 Mil |
| Fund Total Assets: | $ 14 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 109% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 5.9 years | |||
| Average Tenure: 5.9 years | |||
| Managers (Year): Liu Xiang (2020), Xie Erin (2020) | |||
Portfolio Composition (as of 8/31/26)
| # of Holdings: | 60 |
| % in Top 10 Holdings: | 42.4% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 9.3% |
Portfolio Allocation |
|
| Domestic Stock: | 89.7% |
| Foreign Stock: | 9.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 1.1% |
Purchase Information
| Fund Family: | BlackRock |
| Phone Number: | 800-474-2737 |
| Website: | www.blackrock.com |
| Status: | Open |
| Inception Date: | September 29, 2020 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.55% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | iShares Health Innovation Active ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.